University of Maryland Greenebaum Comprehensive Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21201.
Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Maryland Greenebaum Comprehensive Cancer Center has participated in 33 clinical trials with 22 currently active.
Therapeutic areas: Relapsed/Refractory Diffuse Large B-cell Lymphoma, Triple Negative Breast Cancer, Hormone-Resistant Breast Cancer.
Sponsors: Karyopharm Therapeutics Inc, A&G Pharmaceutical Inc., BeiGene.
Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Maryland Greenebaum Comprehensive Cancer Center has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Maryland Greenebaum Comprehensive Cancer Center has 33 clinical trials on record, with 22 currently active. Their work covers Relapsed/Refractory Diffuse Large B-cell Lymphoma, Triple Negative Breast Cancer, Hormone-Resistant Breast Cancer.
University of Maryland Greenebaum Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.